0001144204-16-096035.txt : 20160425
0001144204-16-096035.hdr.sgml : 20160425
20160425150743
ACCESSION NUMBER: 0001144204-16-096035
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160425
DATE AS OF CHANGE: 20160425
EFFECTIVENESS DATE: 20160425
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NQ HCIF GP, Ltd.
CENTRAL INDEX KEY: 0001598203
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16645
FILM NUMBER: 161588807
BUSINESS ADDRESS:
STREET 1: 4208 SIX FORKS ROAD
STREET 2: SUITE 920
CITY: RALEIGH
STATE: NC
ZIP: 27609
BUSINESS PHONE: (919) 459-8620
MAIL ADDRESS:
STREET 1: 4208 SIX FORKS ROAD
STREET 2: SUITE 920
CITY: RALEIGH
STATE: NC
ZIP: 27609
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001598203
XXXXXXXX
03-31-2016
03-31-2016
false
NQ HCIF GP, Ltd.
4208 Six Forks Road
Suite 920
Raleigh
NC
27609
13F HOLDINGS REPORT
028-16645
Y
The securities listed in the table below are held by NovaQuest Pharma Opportunities Fund III, L.P. ("NovaQuest"). NQ HCIF General Partner, L.P., the general partner of NovaQuest ("NovaQuest GP"), may be deemed to exercise investment discretion with respect to the securities directly owned by NovaQuest, and NQ HCIF GP, Ltd., the general partner of NovaQuest GP ("NovaQuest GP Ltd."), may be deemed to direct NovaQuest GP as to such investment discretion. The filing of this report or any related report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g) or 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, or for any other purpose, that NovaQuest GP, NovaQuest GP Ltd. or any other person exercises investment discretion with respect to the securities listed herein or is a member of, or is otherwise affiliated with, such a group with respect to such securities. Reference is made, where relevant, to reports filed under Sections 13(d), 13(g) and 16(a) of the Exchange Act for additional information with respect to such beneficial ownership and/or pecuniary interest of NovaQuest GP and NovaQuest GP Ltd. The filing of this report or any related report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g) or 16(a) of the Exchange Act and the rules thereunder, or for any other purpose, that NovaQuest GP and NovaQuest GP Ltd. or any other person is the beneficial owner of any securities.
John L. Bradley, Jr.
Director
919-459-8622
/s/ John L. Bradley, Jr.
Raleigh
NC
04-25-2016
2
1
54068
2
0001506260
028-16648
NovaQuest Pharma Opportunities Fund III, L.P.
3
0001598327
028-16646
NQ HCIF General Partner, L.P.
INFORMATION TABLE
2
infotable.xml
REVANCE THERAPEUTICS, INC.
COM
761330109
54068
3096650
SH
DFND
2, 3
3096650
0
0